Selinexor in Combination with Salvage Regimen for Refractory Peripheral T-Cell Lymphoma (PTCL) Patients

被引：0
|
作者：
Wang, Li [1 ,2 ]
Cai, Mingci [1 ]
Huang, Yaohui [1 ]
Xu, Pengpeng [1 ]
Chen, Shu [1 ]
Zhao, Weili [1 ,2 ]
机构：
[1] Shanghai Jiao Tong Univ, Shanghai Inst Hematol, State Key Lab Med Genom,Sch Med, Natl Res Ctr Translat Med Shanghai,Rui Jin Hosp, Shanghai, Peoples R China
[2] Chinese French Res Ctr Living Sci & Genom, Lab Mol Pathol, Shanghai, Peoples R China
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-183040
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Outcomes Following Salvage Therapy in Primary Refractory Peripheral T-Cell Lymphoma (PTCL)
    Zhang, Janie Y.
    Briski, Robert
    Devata, Sumana
    Kaminski, Mark S.
    Phillips, Tycel
    Mayer, Tera
    Bailey, Nathanael G.
    Wilcox, Ryan A.
    BLOOD, 2016, 128 (22)
  • [2] PERIPHERAL T-CELL LYMPHOMA PTCL
    Hamed, Hanan
    LEUKEMIA RESEARCH, 2017, 61 : S10 - S11
  • [3] Pralatrexate Induces Responses in Patients with Highly Refractory Peripheral T-Cell Lymphoma (PTCL).
    Pettengell, Ruth
    Coiffier, Bertrand
    Narayanan, Geetha
    Hurtado de Mendoza, Fernando
    Digumarti, Raghunadharao
    Gomez, Henry
    Zinzani, Pier Luigi
    Schiller, Gary J.
    Rizzieri, David A.
    Cernohous, Paul
    Wang, Lixia
    Singer, Jack W.
    BLOOD, 2009, 114 (22) : 669 - 669
  • [4] A Phase 2 Study of Panobinostat (PAN) in Combination with Bortezomib (BTZ) in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL) or NK/T-Cell Lymphoma (NKL)
    Goh, Yeow-Tee
    Hwang, William Y. K.
    Diong, Colin Phipps
    Hsien, Yap Chun
    Tay, Kevin
    Lim, Soon Thye
    Lee, Yuh Shan
    Ng, Soo Chin
    Fadilah, S.
    Kim, Won Seog
    Tan, Daryl
    BLOOD, 2014, 124 (21)
  • [5] Gemcitabine-based combination regimen in patients with peripheral T-cell lymphoma
    Dong, Mei
    He, Xiao-hui
    Liu, Peng
    Qin, Yan
    Yang, Jian-liang
    Zhou, Sheng-yu
    Yang, Sheng
    Zhang, Chang-gong
    Gui, Lin
    Zhou, Li-qiang
    Shi, Yuan-kai
    MEDICAL ONCOLOGY, 2013, 30 (01)
  • [6] Gemcitabine-based combination regimen in patients with peripheral T-cell lymphoma
    Mei Dong
    Xiao-hui He
    Peng Liu
    Yan Qin
    Jian-liang Yang
    Sheng-yu Zhou
    Sheng Yang
    Chang-gong Zhang
    Lin Gui
    Li-qiang Zhou
    Yuan-kai Shi
    Medical Oncology, 2013, 30
  • [7] Survival following salvage therapy for primary refractory peripheral T-cell lymphomas (PTCL)
    Zhang, Janie Y.
    Briski, Robert
    Devata, Sumana
    Kaminski, Mark S.
    Phillips, Tycel J.
    Mayer, Tera L.
    Bailey, Nathanael G.
    Wilcox, Ryan A.
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (03) : 394 - 400
  • [8] PRALATREXATE REVERSES THE TREND TO PROGRESSIVE RESISTANCE IN PATIENTS WITH RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMA (PTCL)
    Coiffier, B.
    Zinzani, P.
    Koutsoukos, A.
    O'Connor, O.
    ANNALS OF ONCOLOGY, 2011, 22 : 202 - 202
  • [9] Selinexor in Combination with Salvage Regimen for Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients with TP53 Alterations
    Wang, Li
    Fang, Ying
    Zhang, Muchen
    Xiong, Jie
    Xu, Pengpeng
    Chen, Shu
    Zhao, Weili
    BLOOD, 2023, 142
  • [10] Pralatrexate in patients with relapsed/refractory peripheral T-cell lymphoma (PTCL): Relationship between response and survival
    Shustov, A. R.
    Pro, B.
    Horwitz, S. M.
    Jacobsen, E. D.
    Boyd, A.
    Fruchtman, S. M.
    O'Connor, O.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345